lse:azn

New drug approval by FDA [Market Discussions] (1)
EU approval in the pipeline [Market Discussions] (1)
AZN cancer drug granted breakthrough therapy designation [Market Discussions] (1)
quiet [Market Discussions] (2)
Bydureon Trial Results [Market Discussions] (1)
Update on clinical trials [Market Discussions] (2)
Positive drug trial reported. [Market Discussions] (1)
Madrid oncology conference [Market Discussions] (1)
LSE:AZN [Market Discussions] (1)
LSE:AZN [Market Discussions] (1)
LSE:AZN [Market Discussions] (1)
Merck /Astrazeneca oncology collaboration [Market Discussions] (1)
FDA approval for Faslodex [Market Discussions] (1)
Drugmaker news roundup [Market Discussions] (1)
NEW ARTICLE: Stockwatch: Is this a coiled spring or a falling knife? [Market Discussions] (2)
AstraZeneca Stages Major Lung Cancer Comeback [Market Discussions] (1)
Telegraph article [Market Discussions] (1)
SP slump unwarranted - says Neil Woodford [Market Discussions] (13)
NEW ARTICLE: The 10 most popular funds - July 2017 [Market Discussions] (1)
That boy Terry sticks the boot in! [Market Discussions] (8)
AZN and GSK [Market Discussions] (1)
Woody's fortnight from hxll [Market Discussions] (1)
FT article [Market Discussions] (3)
Nowhere to Run to Baby !! [Market Discussions] (1)
AZN article in Shares mag [Market Discussions] (1)
Shire [Market Discussions] (1)
AstraZeneca Stages Major Lung Cancer Comeback [Market Discussions] (1)
Correlation - Fundsmith ( 2 ) [Market Discussions] (24)
Would you invest in..... [Market Discussions] (1)
Downgrade [Market Discussions] (1)